Literature DB >> 19757439

Antigen-dependent rescue of nose-associated lymphoid tissue (NALT) development independent of LTbetaR and CXCR5 signaling.

Janet Krege1, Sebastian Seth, Svenja Hardtke, Ana Clara Marques Davalos-Misslitz, Reinhold Förster.   

Abstract

Nose-associated lymphoid tissue (NALT) in the rodent upper respiratory tract develops postnatally and is considered to be independent of several factors known to be involved in the organogenesis of LN and Peyer's patches (PP). In this study we demonstrate that at least two different pathways result in NALT development. Following NALT anlage formation the intrinsic pathway relies on a signaling cascade including those mediated through the chemokine receptor CXCR5 and the lymphotoxin beta receptor (LTbetaR). This allows for the formation of high endothelial venules and thereby the recruitment of lymphocytes into NALT. Alternatively, high endothelial venule formation and lymphocyte recruitment can be induced in the NALT anlage by environmental signals, which are independent of LT-betaR and chemokine receptor CXCR5 signaling but in part rely on CD40 ligand. Thus, our study identifies a novel mechanism that facilitates the rescue of NALT development at late stages in adult life independent of the canonical LTbetaR-CXCR5 signaling axis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19757439     DOI: 10.1002/eji.200939422

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  New insights into the development of lymphoid tissues.

Authors:  Serge A van de Pavert; Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

Review 2.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

Review 3.  The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms.

Authors:  T D Randall; R E Mebius
Journal:  Mucosal Immunol       Date:  2014-02-26       Impact factor: 7.313

Review 4.  The evolution of nasal immune systems in vertebrates.

Authors:  Ali Sepahi; Irene Salinas
Journal:  Mol Immunol       Date:  2015-09-19       Impact factor: 4.407

Review 5.  Mucosal Immune Response in Nasal-Associated Lymphoid Tissue upon Intranasal Administration by Adjuvants.

Authors:  Hiromi Takaki; Shingo Ichimiya; Misako Matsumoto; Tsukasa Seya
Journal:  J Innate Immun       Date:  2018-06-01       Impact factor: 7.349

6.  Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestine.

Authors:  Cornelia Lindner; Benjamin Wahl; Lisa Föhse; Sebastian Suerbaum; Andrew J Macpherson; Immo Prinz; Oliver Pabst
Journal:  J Exp Med       Date:  2012-01-16       Impact factor: 14.307

7.  Co-localization of lymphoid aggregates and lymphatic networks in nose- (NALT) and lacrimal duct-associated lymphoid tissue (LDALT) of mice.

Authors:  Melanie Lohrberg; Reinhard Pabst; Jörg Wilting
Journal:  BMC Immunol       Date:  2018-01-25       Impact factor: 3.615

Review 8.  Tertiary lymphoid organs in infection and autoimmunity.

Authors:  Katrijn Neyt; Frédéric Perros; Corine H GeurtsvanKessel; Hamida Hammad; Bart N Lambrecht
Journal:  Trends Immunol       Date:  2012-05-21       Impact factor: 16.687

9.  IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs.

Authors:  Henrike Fleige; Sarina Ravens; Georgios Leandros Moschovakis; Jasmin Bölter; Stefanie Willenzon; Gerd Sutter; Susanne Häussler; Ulrich Kalinke; Immo Prinz; Reinhold Förster
Journal:  J Exp Med       Date:  2014-03-24       Impact factor: 14.307

Review 10.  Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung.

Authors:  Ji Young Hwang; Troy D Randall; Aaron Silva-Sanchez
Journal:  Front Immunol       Date:  2016-06-30       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.